{"title":"Synthesis of Ursolic Acid-based Hybrids: <i>In Vitro</i> Antibacterial, Cytotoxicity Studies, <i>In Silico</i> Physicochemical and Pharmacokinetic Properties.","authors":"Vuyolwethu Khwaza, Samson Olaitan Oselusi, Eric Morifi, Mutshinyalo Nwamadi, Kamogelo S Hlope, Derek Tantoh Ndinteh, Thabe Moses Matsebatlela, Opeoluwa Oyehan Oyedeji, Blessing Atim Aderibigbe","doi":"10.2174/0127724344272444231114103144","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is a critical need for the discovery of novel and effective antibacterial or anticancer molecules.</p><p><strong>Objectives: </strong>Amine-linked ursolic acid-based hybrid compounds were prepared in good yields in the range of 60-68%.</p><p><strong>Methods: </strong>Their molecular structures were successfully confirmed using different spectroscopic methods including <sup>1</sup>H/<sup>13</sup>C NMR, UHPLC-HRMS and FTIR spectroscopy. The <i>in vitro</i> cytotoxicity of some of these hybrid molecules against three human tumour cells, such as MDA-MB23, MCF7, and HeLa was evaluated using the MTT colorimetric method.</p><p><strong>Result: </strong>Their antibacterial efficacy was evaluated against eleven bacterial pathogens using a serial dilution assay. Majority of the bacterial strains were inhibited significantly by compounds 17 and 24, with the lowest MIC values in the range of 15.3-31.25 μg/mL. Compound 16 exhibited higher cytotoxicity against HeLa cells than ursolic acid, with an IC<sub>50</sub> value of 43.64 g/mL.</p><p><strong>Conclusion: </strong>The in vitro antibacterial activity and cytotoxicity of these hybrid compounds demonstrated that ursolic acid-based hybrid molecules are promising compounds. Further research into ursolic acid-based hybrid compounds is required.</p>","PeriodicalId":74643,"journal":{"name":"Recent advances in anti-infective drug discovery","volume":" ","pages":"232-253"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent advances in anti-infective drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0127724344272444231114103144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: There is a critical need for the discovery of novel and effective antibacterial or anticancer molecules.
Objectives: Amine-linked ursolic acid-based hybrid compounds were prepared in good yields in the range of 60-68%.
Methods: Their molecular structures were successfully confirmed using different spectroscopic methods including 1H/13C NMR, UHPLC-HRMS and FTIR spectroscopy. The in vitro cytotoxicity of some of these hybrid molecules against three human tumour cells, such as MDA-MB23, MCF7, and HeLa was evaluated using the MTT colorimetric method.
Result: Their antibacterial efficacy was evaluated against eleven bacterial pathogens using a serial dilution assay. Majority of the bacterial strains were inhibited significantly by compounds 17 and 24, with the lowest MIC values in the range of 15.3-31.25 μg/mL. Compound 16 exhibited higher cytotoxicity against HeLa cells than ursolic acid, with an IC50 value of 43.64 g/mL.
Conclusion: The in vitro antibacterial activity and cytotoxicity of these hybrid compounds demonstrated that ursolic acid-based hybrid molecules are promising compounds. Further research into ursolic acid-based hybrid compounds is required.